JP2024500920A5 - - Google Patents
Info
- Publication number
- JP2024500920A5 JP2024500920A5 JP2023538679A JP2023538679A JP2024500920A5 JP 2024500920 A5 JP2024500920 A5 JP 2024500920A5 JP 2023538679 A JP2023538679 A JP 2023538679A JP 2023538679 A JP2023538679 A JP 2023538679A JP 2024500920 A5 JP2024500920 A5 JP 2024500920A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antigen
- binding fragment
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20216926.4 | 2020-12-23 | ||
| EP20216926 | 2020-12-23 | ||
| GBGB2105933.2A GB202105933D0 (en) | 2021-04-26 | 2021-04-26 | Anti-IL1rap antibody |
| GB2105933.2 | 2021-04-26 | ||
| EP21212368 | 2021-12-03 | ||
| EP21212368.1 | 2021-12-03 | ||
| PCT/EP2021/087338 WO2022136569A1 (en) | 2020-12-23 | 2021-12-22 | Anti-il1rap antibody |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024500920A JP2024500920A (ja) | 2024-01-10 |
| JP2024500920A5 true JP2024500920A5 (https=) | 2025-01-06 |
Family
ID=79731073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023538679A Pending JP2024500920A (ja) | 2020-12-23 | 2021-12-22 | 抗ｉｌ１ｒａｐ抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11479610B2 (https=) |
| EP (1) | EP4267625A1 (https=) |
| JP (1) | JP2024500920A (https=) |
| KR (1) | KR20230123962A (https=) |
| AU (1) | AU2021405730A1 (https=) |
| CA (1) | CA3202942A1 (https=) |
| IL (1) | IL303922A (https=) |
| MX (1) | MX2023007611A (https=) |
| WO (1) | WO2022136569A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020035577A1 (en) | 2018-08-16 | 2020-02-20 | Cantargia Ab | Anti-il1rap antibody compositions |
| EP4267625A1 (en) * | 2020-12-23 | 2023-11-01 | Cantargia AB | Anti-il1rap antibody |
| CA3220913A1 (en) | 2021-05-21 | 2022-11-24 | Leo Pharma A/S | Anti il-1 receptor accessory protein antibodies |
| AR130550A1 (es) | 2022-09-21 | 2024-12-18 | Sanofi Biotechnology | Anticuerpo anti-il-1r3 humanizado y métodos de uso |
| CN116284401B (zh) * | 2023-02-20 | 2024-09-24 | 中国人民解放军军事科学院军事医学研究院 | 人源抗il-1r3抗体及其应用 |
| EP4705340A1 (en) | 2023-05-05 | 2026-03-11 | Otsuka Pharmaceutical Co., Ltd. | Anti-il1rap antibodies |
| CN120775048A (zh) * | 2024-04-02 | 2025-10-14 | 信达生物制药(苏州)有限公司 | 抗il1rap抗体以及其用途 |
| WO2026022232A1 (en) | 2024-07-24 | 2026-01-29 | Almirall, S.A. | Il-1rap inhibitor for treating or preventing hidradenitis suppurativa |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| SE459005B (sv) | 1985-07-12 | 1989-05-29 | Aake Rikard Lindahl | Saett att framstaella sfaeriska polymerpartiklar |
| CA2192782C (en) | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production of microspheres |
| CA2704600C (en) | 1999-04-09 | 2016-10-25 | Kyowa Kirin Co., Ltd. | A method for producing antibodies with increased adcc activity |
| US7960512B2 (en) | 2003-01-09 | 2011-06-14 | Macrogenics, Inc. | Identification and engineering of antibodies with variant Fc regions and methods of using same |
| AU2005274905B2 (en) | 2004-08-04 | 2010-12-23 | Mentrik Biotech, Llc | Variant Fc regions |
| GB2472856B (en) | 2009-08-21 | 2012-07-11 | Cantargia Ab | IL1-RAP modulators and uses thereof |
| US9403906B2 (en) | 2011-01-19 | 2016-08-02 | Cantargia Ab | Method of treatment of a solid tumor with interleukin-1 accessory protein antibody |
| GB201403875D0 (en) | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
| JP7114460B2 (ja) * | 2015-06-26 | 2022-08-08 | サノフィ・バイオテクノロジー | モノクローナル抗ＩＬ－１ＲＡｃＰ抗体 |
| CA3084459A1 (en) * | 2016-10-16 | 2018-04-19 | Cellerant Therapeutics, Inc. | Anti-il1-rap antibodies |
| AU2018312563A1 (en) | 2017-08-01 | 2020-03-12 | City Of Hope | Anti-IL1RAP antibodies |
| WO2020035577A1 (en) | 2018-08-16 | 2020-02-20 | Cantargia Ab | Anti-il1rap antibody compositions |
| TW202021618A (zh) | 2018-08-17 | 2020-06-16 | 美商２３與我有限公司 | 抗ｉｌ１ｒａｐ抗體及其使用方法 |
| EP4267625A1 (en) * | 2020-12-23 | 2023-11-01 | Cantargia AB | Anti-il1rap antibody |
-
2021
- 2021-12-22 EP EP21844985.8A patent/EP4267625A1/en active Pending
- 2021-12-22 AU AU2021405730A patent/AU2021405730A1/en active Pending
- 2021-12-22 JP JP2023538679A patent/JP2024500920A/ja active Pending
- 2021-12-22 US US17/559,227 patent/US11479610B2/en active Active
- 2021-12-22 WO PCT/EP2021/087338 patent/WO2022136569A1/en not_active Ceased
- 2021-12-22 KR KR1020237020863A patent/KR20230123962A/ko active Pending
- 2021-12-22 IL IL303922A patent/IL303922A/en unknown
- 2021-12-22 MX MX2023007611A patent/MX2023007611A/es unknown
- 2021-12-22 CA CA3202942A patent/CA3202942A1/en active Pending
-
2022
- 2022-06-09 US US17/836,457 patent/US12043666B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024500920A5 (https=) | ||
| JP2017530692A5 (https=) | ||
| JP7820383B2 (ja) | グリピカン－３およびｔ細胞受容体を標的とする免疫グロブリン単一可変ドメインを含むポリペプチド | |
| JP2021530229A5 (https=) | ||
| JP7849699B2 (ja) | インターロイキン３６ｒを標的とする抗体、その調製法と応用 | |
| JP2021518133A5 (https=) | ||
| JP2023508174A5 (https=) | ||
| JP2023509402A5 (https=) | ||
| KR102683288B1 (ko) | Il-17a-결합 폴리펩티드 | |
| CN102439040A (zh) | 抗TNF-α抗体和其用途 | |
| JP2017526339A (ja) | 抗Ａｘｌ抗体 | |
| JP2017519501A (ja) | 抗Ａｘｌ抗体 | |
| JP2022527151A5 (https=) | ||
| AU2021390121A1 (en) | Anti-human b7-h3 antibody and application thereof | |
| TWI815136B (zh) | 一種雙特異性抗體及其用途 | |
| JP2023508173A5 (https=) | ||
| IL261031B2 (en) | Antibodies against TNF-alpha and their functional fragments | |
| CN117285627A (zh) | 抗ccr8抗体及其用途 | |
| JP7049311B2 (ja) | 抗ＴＮＦα抗体およびそれらの機能的断片 | |
| IL261098B2 (en) | Antibodies against TNF-ALPHA and their functional fragments | |
| JP2023546758A5 (https=) | ||
| JP2023507280A (ja) | ヒトｉｌ－１３及びｉｌ－１７に対する結合特異性を有する多重特異性抗体 | |
| KR20180120763A (ko) | 항TNFα 항체 및 이의 기능성 단편 | |
| CN121263442A (zh) | 抗il1rap抗体 | |
| US20190225680A1 (en) | Tenascin Epitope and Antibodies Thereto |